Embedded Files
IMARC Group’s report titled "Allergy Treatment Market Report by Type (Eye Allergy, Skin Allergy, Food Allergy, Asthma, Rhinitis, and Others), Treatment (Anti-Allergy Drugs, Immunotherapy), Dosage Form (Oral, Inhalers, Intranasal, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Retailers, and Others), and Region 2024-2032. The global allergy treatment market size reached US$ 22.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 35.5 Billion by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032.
Grab a sample PDF of this report: https://www.imarcgroup.com/allergy-treatment-market/requestsample
Factors Affecting the Growth of the Allergy Treatment Industry:
Growing Prevalence of Allergic Disorders:
The increasing prevalence of allergic disorders worldwide, such as allergic rhinitis, asthma, and food allergies, is impelling the growth of the market. Environmental factors, including rising pollution levels, climate change, and urbanization, are contributing to the heightened incidence of allergies, particularly in urban areas. Additionally, lifestyle changes, such as dietary habits and exposure to allergens, are exacerbating the frequency and severity of allergic reactions. As more individuals seek medical intervention to manage symptoms, the demand for effective allergy treatments, including antihistamines, decongestants, and immunotherapy, is rising. This trend is particularly evident in developed regions where awareness and diagnosis rates are higher.
Advancements in Allergy Treatment and Diagnostic Technologies:
Technological advancements in the diagnosis and treatment of allergies are significantly propelling the market growth. Innovations in diagnostic tools, such as advanced blood tests, skin prick tests, and molecular diagnostics, enable precise identification of specific allergens, allowing for more targeted and effective treatments. Moreover, the development of new treatment options, including biologics and sublingual immunotherapy, is expanding the range of therapeutic solutions available to patients. These cutting-edge treatments not only improve patient outcomes but also cater to individuals who may not respond well to traditional therapies.
Increasing Awareness and Patient Education:
Rising awareness about allergic conditions and the importance of early diagnosis and treatment is supporting the market growth. Public health campaigns, educational initiatives by healthcare providers, and the growing availability of information through digital platforms are making individuals more informed about allergy symptoms, triggers, and treatment options. This increased awareness encourages more people to seek medical advice and adhere to prescribed treatments, leading to better management of their conditions. In addition, healthcare providers are focusing on personalized treatment plans and patient awareness to improve compliance and outcomes.
Leading Companies Operating in the Global Allergy Treatment Industry:
AbbVie Inc.
ALK-Abelló A/S
Allergopharma (Dermapharm AG)
Allergy Therapeutics
Almirall S.A
AstraZeneca plc
Bayer AG
Boehringer Ingelheim International GmbH
HAL Allergy Group (Droege International Group)
Leti Pharma
Nicox S.A.
Sanofi S.A.
Stallergenes Greer.
Allergy Treatment Market Report Segmentation:
By Type:
Eye Allergy
Skin Allergy
Food Allergy
Asthma
Rhinitis
Others
Rhinitis exhibits a clear dominance in the market due to its high prevalence and the substantial demand for effective symptom management among affected individuals.
By Treatment:
Anti-Allergy Drugs
Immunotherapy
Anti-allergy drugs represent the largest segment because they provide quick and accessible relief, making them the first-line treatment for most allergic conditions.
By Dosage From:
Oral
Inhalers
Intranasal
Others
Based on the dosage form, the market has been categorized into oral, inhalers, intranasal, and others.
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Retailers
Others
On the basis of the distribution channel, the market has been segregated into hospital pharmacies, retail pharmacies, online retailers, and others.
Regional Insights:
North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
North America dominates the market owing to its advanced healthcare infrastructure, high awareness levels, and significant investments in allergy research and treatment.
Global Allergy Treatment Market Trends:
The growing adoption of immunotherapy, particularly subcutaneous and sublingual immunotherapy, is offering a favorable market outlook. Immunotherapy is gaining popularity as it offers a long-term solution for managing allergies by modifying the response of the immune system to allergens. Unlike traditional symptomatic treatments, immunotherapy targets the root cause of allergies, providing sustained relief even after the treatment course has ended. As clinical studies continue to demonstrate the efficacy and safety of immunotherapy, more healthcare providers are recommending it as a preferred treatment option. This trend is particularly noticeable in developed regions, where patients and physicians are increasingly opting for personalized and preventive healthcare solutions. The availability of new formulations, such as tablets and drops, is also making immunotherapy more convenient and accessible to a broader patient population.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
Page updated
Google Sites
Report abuse